State Street Corp Vertex Pharmaceuticals Inc Put Options Transaction History
State Street Corp
- $2.41 Trillion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VRTX
# of Institutions
1,722Shares Held
222MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$12.5 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$10.8 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.93 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.19 Billion0.9% of portfolio
-
Alliancebernstein L.P. New York, NY7.37MShares$3.43 Billion1.19% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $120B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...